Published in Hepatitis Weekly, February 4th, 2002
More specifically, information about hepatitis B and C virus (HBV, HCV) infection rates cannot be extended from information gathered at treatment centers to wider population groups when looking at injection drug users, according to P.A. Cook and colleagues of Liverpool John Moores University School of Health and Human Sciences in England.
Cook and associates conducted a cross-sectional survey of HBV...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.